Geovax appoints teresa lambe, acclaimed professor of vaccinology and immunology at the oxford vaccine group, to its scientific advisory board

Strategic appointment enhances geovax's leadership and expertise in vaccine development atlanta, ga, aug. 08, 2024 (globe newswire) -- geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced the appointment of teresa lambe, phd, obe, fmedsci to its scientific advisory board. professor lambe is the calleva head of vaccine immunology at the oxford vaccine group within the university of oxford and a principal investigator at the pandemic sciences institute (psi).
GOVX Ratings Summary
GOVX Quant Ranking